Thank you to everyone who participated in our early psychosis research priorities poll last month. Over 320 people from research, clinical and/or lived experience backgrounds voted, which was a great result.
Of the 10 research questions listed in the poll, the clear priority overall, and among each of the three audiences was:
What treatments deliver the best long-term outcomes for people with early psychosis?
AEPCC’s Lived Experience Network Coordinator, Dee De Cicco, explains why this research question is so important:
“When young people are diagnosed with early psychosis it often feels like a death sentence, as if the bar is going to be set low for your entire life.
When we focus research on what treatments would create the best long-term outcomes, we are telling them there is hope.
We are ensuring when they walk out our door, they are being given the best chance of not needing to come back.”
AEPCC Principal Investigator, Professor Andrew Thompson, is looking forward to focusing on this understudied area of research:
“Studying short-term outcomes for young people receiving treatment for early psychosis, such as symptom improvement, is important. However, we know much less about how to support young people in the longer term.
Research into continual improvement and quality of life outcomes is essential and fits perfectly with AEPCC’s vision.”
If you are a researcher and designing a clinical trial in this area, please get in touch by emailing: [email protected]
If you entered the draw for a $50 voucher when you answered the poll, you’ll be contacted this week if your name was pulled out of the box!
Early next year we’ll be in touch with more details on:
- How AEPCC will be facilitating clinical trials
- The AEPCC Clinical Quality Registry launch
- Building the early psychosis lived experience network
We hope you have a lovely break and look forward to working with you in 2024!
